Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$24.75 - $40.66 $4,405 - $7,237
-178 Reduced 0.85%
20,795 $515,000
Q4 2023

Feb 13, 2024

BUY
$32.31 - $52.32 $9,143 - $14,806
283 Added 1.37%
20,973 $762,000
Q3 2023

Nov 13, 2023

BUY
$47.3 - $70.6 $34,812 - $51,961
736 Added 3.69%
20,690 $998,000
Q2 2023

Aug 04, 2023

BUY
$48.26 - $78.59 $51,589 - $84,012
1,069 Added 5.66%
19,954 $1.36 Million
Q1 2023

May 12, 2023

BUY
$46.97 - $58.27 $72,380 - $89,794
1,541 Added 8.88%
18,885 $915,000
Q4 2022

Feb 10, 2023

BUY
$52.05 - $65.0 $26,129 - $32,630
502 Added 2.98%
17,344 $1.04 Million
Q3 2022

Nov 14, 2022

BUY
$25.16 - $60.63 $5,988 - $14,429
238 Added 1.43%
16,842 $1.02 Million
Q2 2022

Aug 12, 2022

SELL
$22.73 - $39.98 $30,549 - $53,733
-1,344 Reduced 7.49%
16,604 $451,000
Q1 2022

May 13, 2022

SELL
$30.27 - $49.22 $38,261 - $62,214
-1,264 Reduced 6.58%
17,948 $656,000
Q4 2021

Feb 11, 2022

BUY
$42.11 - $73.26 $3,453 - $6,007
82 Added 0.43%
19,212 $949,000
Q3 2021

Nov 12, 2021

BUY
$48.2 - $78.89 $1,108 - $1,814
23 Added 0.12%
19,130 $1.36 Million
Q2 2021

Aug 13, 2021

BUY
$21.63 - $57.65 $25,415 - $67,738
1,175 Added 6.55%
19,107 $982,000
Q1 2021

May 07, 2021

BUY
$11.0 - $28.24 $528 - $1,355
48 Added 0.27%
17,932 $450,000
Q4 2020

Feb 12, 2021

SELL
$10.12 - $13.94 $5,201 - $7,165
-514 Reduced 2.79%
17,884 $215,000
Q3 2020

Nov 04, 2020

SELL
$9.93 - $13.47 $4,140 - $5,616
-417 Reduced 2.22%
18,398 $184,000
Q2 2020

Aug 12, 2020

SELL
$9.56 - $12.51 $47,647 - $62,349
-4,984 Reduced 20.94%
18,815 $197,000
Q1 2020

May 04, 2020

SELL
$7.54 - $15.77 $10,367 - $21,683
-1,375 Reduced 5.46%
23,799 $255,000
Q4 2019

Feb 05, 2020

SELL
$7.48 - $17.01 $1,585 - $3,606
-212 Reduced 0.84%
25,174 $399,000
Q3 2019

Nov 08, 2019

SELL
$6.89 - $10.45 $1,212 - $1,839
-176 Reduced 0.69%
25,386 $199,000
Q2 2019

Aug 23, 2019

BUY
$8.85 - $12.49 $226,223 - $319,269
25,562 New
25,562 $270,000
Q2 2019

Aug 13, 2019

SELL
$8.85 - $12.49 $226,745 - $320,006
-25,621 Closed
0 $0
Q1 2019

May 06, 2019

SELL
$10.32 - $14.49 $8,575 - $12,041
-831 Reduced 3.14%
25,621 $311,000
Q4 2018

Feb 13, 2019

SELL
$8.73 - $13.74 $1,780 - $2,802
-204 Reduced 0.77%
26,452 $272,000
Q3 2018

Nov 09, 2018

BUY
$12.7 - $15.79 $6,108 - $7,594
481 Added 1.84%
26,656 $349,000
Q2 2018

Aug 08, 2018

BUY
$10.99 - $44.21 $14,869 - $59,816
1,353 Added 5.45%
26,175 $382,000
Q1 2018

May 07, 2018

SELL
$27.95 - $45.04 $29,207 - $47,066
-1,045 Reduced 4.04%
24,822 $911,000
Q4 2017

Feb 09, 2018

BUY
$35.44 - $63.76 $4,288 - $7,714
121 Added 0.47%
25,867 $970,000
Q3 2017

Nov 09, 2017

BUY
$53.83 - $67.75 $1.39 Million - $1.74 Million
25,746
25,746 $1.67 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $668M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.